APH - CIK 0000820313
The table below shows AMPHENOL CORP /DE/'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.12B | - | - | $764.90M | - | - |
| Capital expenditure | $291.60M | - | - | $188.60M | - | - |
| Investing cash flow | -$11.03B | - | - | -$2.35B | - | - |
| Dividends paid | $306.70M | $201.20M | $199.60M | $199.50M | $132.40M | $132.10M |
AMPHENOL CORP /DE/ reported operating cash flow of $5.37B for fiscal year 2025. That is up 91.0% from $2.81B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $1.08B (FY 2016) to $5.37B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $178.00M | - | - | $180.90M | - | - |
| Financing cash flow | $2.90B | - | - | -$88.60M | - | - |